0.00
price down icon100.00%   -8.05
after-market After Hours: 8.09 8.09 +
loading

Why is Vigil Neuroscience Inc (VIGL) Stock down?

17 Nov, 2023:

Vigil Neuroscience Stock (VIGL) dropped by 40.03% from $6.67 to $4.00 in the trading on Friday November 17, 2023. The reason why VIGL stock down today is due to the interim data from its Phase 2 IGNITE proof-of-concept clinical trial in patients with ALSP. The data, representing the first six patients following six months of treatment with 20 mg/kg of iluzanebart, supports the drug's safety and tolerability, and showed target engagement and downstream pharmacological activity, consistent with Phase 1 data. Directionally supportive changes were observed on MRI and NfL biomarkers of disease progression in individual patients, and the company expects to report full Phase 2 IGNITE results in Q3 2024.

$20.95
price up icon 3.41%
$82.70
price up icon 1.27%
$29.07
price up icon 0.80%
$98.08
price up icon 0.00%
$137.03
price up icon 1.06%
biotechnology ONC
$326.06
price down icon 0.81%
Cap:     |  Volume (24h):